See more : Cambridge Nutritional Sciences plc (CNSL.L) Income Statement Analysis – Financial Results
Complete financial analysis of Sichuan Hebang Biotechnology Corporation Limited (603077.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sichuan Hebang Biotechnology Corporation Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- C.P. Pokphand Co. Ltd. (0043.HK) Income Statement Analysis – Financial Results
- Jiangsu Expressway Company Limited (JEXYY) Income Statement Analysis – Financial Results
- Easyknit International Holdings Limited (1218.HK) Income Statement Analysis – Financial Results
- Foothills Exploration, Inc. (FTXP) Income Statement Analysis – Financial Results
- GWA Group Limited (GWA.AX) Income Statement Analysis – Financial Results
Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
About Sichuan Hebang Biotechnology Corporation Limited
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. Sichuan Hebang Biotechnology Corporation Limited was founded in 2002 and is based in Chengdu, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.82B | 13.04B | 9.87B | 5.26B | 5.97B | 6.01B | 4.74B | 3.46B | 2.86B | 2.19B | 1.60B | 1.74B | 1.90B | 1.43B | 844.37M |
| Cost of Revenue | 6.82B | 7.45B | 5.73B | 4.27B | 4.61B | 4.68B | 3.53B | 2.64B | 2.23B | 1.73B | 1.30B | 1.09B | 1.09B | 973.43M | 645.13M |
| Gross Profit | 2.00B | 5.59B | 4.14B | 988.80M | 1.36B | 1.33B | 1.20B | 826.37M | 627.75M | 458.32M | 307.19M | 652.56M | 807.36M | 459.44M | 199.24M |
| Gross Profit Ratio | 22.67% | 42.85% | 41.93% | 18.80% | 22.78% | 22.10% | 25.39% | 23.87% | 21.93% | 20.97% | 19.17% | 37.55% | 42.49% | 32.06% | 23.60% |
| Research & Development | 47.35M | 67.93M | 33.31M | 39.68M | 38.30M | 31.14M | 34.76M | 25.06M | 3.81M | 0.00 | 0.00 | 12.45M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 93.30M | 73.53M | 65.65M | 81.96M | 59.69M | 84.51M | 73.96M | 59.15M | 34.02M | 24.22M | 21.26M | 35.24M | 21.95M | 17.40M | 18.68M |
| Selling & Marketing | 29.64M | 52.48M | 52.09M | 63.93M | 289.57M | 339.40M | 258.74M | 245.19M | 146.82M | 101.28M | 81.56M | 51.89M | 81.65M | 130.65M | 71.72M |
| SG&A | 122.94M | 126.01M | 117.74M | 145.89M | 349.27M | 423.91M | 332.71M | 304.34M | 180.84M | 125.49M | 102.82M | 87.14M | 103.59M | 148.04M | 90.40M |
| Other Expenses | -59.41M | 853.76M | 335.07M | 272.37M | 301.12M | 1.74M | 287.37K | 30.71M | 63.53M | 712.68K | 150.83K | 5.56M | 47.52K | 7.39M | 2.22M |
| Operating Expenses | 459.06M | 1.05B | 486.12M | 457.94M | 688.69M | 686.47M | 556.84M | 472.97M | 303.31M | 223.10M | 189.15M | 182.97M | 207.75M | 195.82M | 133.03M |
| Cost & Expenses | 7.28B | 8.50B | 6.22B | 4.73B | 5.30B | 5.37B | 4.09B | 3.11B | 2.54B | 1.95B | 1.48B | 1.27B | 1.30B | 1.17B | 778.16M |
| Interest Income | 60.35M | 22.69M | 9.36M | 3.66M | 6.91M | 6.84M | 7.26M | 4.26M | 1.36M | 1.01M | 11.48M | 11.49M | 599.24K | 1.09M | 5.30M |
| Interest Expense | 24.37M | 51.43M | 77.82M | 82.16M | 57.04M | 58.31M | 61.90M | 112.74M | 120.32M | 133.77M | 82.29M | 118.77M | 129.68M | 80.47M | 23.62M |
| Depreciation & Amortization | 1.00B | 930.81M | 645.16M | 645.27M | 636.63M | 575.27M | 525.94M | 417.74M | 322.77M | 268.71M | 197.33M | 195.23M | 202.14M | 153.73M | 72.81M |
| EBITDA | 2.52B | 5.44B | 4.30B | 743.69M | 1.28B | 1.05B | 1.18B | 859.08M | 690.68M | 1.06B | 350.10M | 677.28M | 801.39M | 424.90M | 145.19M |
| EBITDA Ratio | 28.52% | 42.30% | 43.61% | 13.97% | 21.77% | 20.26% | 25.62% | 24.81% | 26.28% | 53.27% | 22.35% | 40.79% | 43.03% | 31.18% | 17.34% |
| Operating Income | 1.54B | 4.48B | 3.60B | 92.01M | 582.66M | 413.96M | 595.80M | 339.01M | 218.75M | 678.73M | 70.34M | 384.22M | 484.95M | 192.89M | 46.54M |
| Operating Income Ratio | 17.47% | 34.37% | 36.44% | 1.75% | 9.76% | 6.89% | 12.58% | 9.79% | 7.64% | 31.05% | 4.39% | 22.11% | 25.52% | 13.46% | 5.51% |
| Total Other Income/Expenses | -5.83M | -2.60M | -17.53M | -424.68M | 1.09M | 1.74M | -16.14M | 22.90M | 63.53M | 712.68K | 150.83K | -74.67M | -111.56M | -52.15M | -16.26M |
| Income Before Tax | 1.54B | 4.48B | 3.58B | 15.81M | 583.75M | 415.69M | 596.08M | 369.59M | 282.27M | 679.44M | 70.49M | 389.78M | 484.95M | 199.13M | 48.76M |
| Income Before Tax Ratio | 17.41% | 34.35% | 36.31% | 0.30% | 9.78% | 6.92% | 12.58% | 10.67% | 9.86% | 31.09% | 4.40% | 22.43% | 25.52% | 13.90% | 5.77% |
| Income Tax Expense | 257.27M | 668.32M | 551.88M | 12.90M | 77.14M | 117.49M | 90.89M | 48.13M | 43.54M | 7.68M | 6.06M | 54.88M | 118.67M | 28.42M | 5.54M |
| Net Income | 1.28B | 3.81B | 3.02B | 2.91M | 516.85M | 363.09M | 517.54M | 317.81M | 239.87M | 671.76M | 64.44M | 334.89M | 366.28M | 172.80M | 44.16M |
| Net Income Ratio | 14.54% | 29.20% | 30.59% | 0.06% | 8.66% | 6.04% | 10.92% | 9.18% | 8.38% | 30.73% | 4.02% | 19.27% | 19.28% | 12.06% | 5.23% |
| EPS | 0.15 | 0.44 | 0.36 | 0.00 | 0.06 | 0.04 | 0.06 | 0.04 | 0.03 | 0.10 | 0.01 | 0.07 | 0.09 | 0.04 | 0.01 |
| EPS Diluted | 0.15 | 0.44 | 0.36 | 0.00 | 0.06 | 0.04 | 0.06 | 0.04 | 0.03 | 0.10 | 0.01 | 0.07 | 0.09 | 0.04 | 0.01 |
| Weighted Avg Shares Out | 8.71B | 8.70B | 8.44B | 8.53B | 8.66B | 8.83B | 8.63B | 7.77B | 7.29B | 6.43B | 6.08B | 5.14B | 4.62B | 3.93B | 3.89B |
| Weighted Avg Shares Out (Dil) | 8.71B | 8.70B | 8.44B | 8.53B | 8.66B | 9.08B | 8.63B | 7.95B | 7.54B | 6.43B | 6.08B | 5.14B | 4.62B | 3.93B | 3.89B |
Source: https://incomestatements.info
Category: Stock Reports